Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference

The company also participated in the H.C. Wainwright BioConnect Conference earlier in January CNS Pharmaceuticals recently received approval from swissethics for a pivotal Berubicin and GBM clinical trial The five-year survival rate for GBM is only 6.8%, with the average patient population surviving 12 to 18 months after diagnosis CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical […]

Cepton Inc.’s (NASDAQ: CPTN) Management Rings Nasdaq Opening Bell After Commencing Formal Trade on the Exchange

Cepton, Inc formally listed on the Nasdaq Capital Market on February 11, 2022, following the merger between Cepton Technologies Inc., and SPAC, Growth Capital Acquisition Corp (GCAC) Cepton’s CEO, Dr. Jun Pei rang the Nasdaq opening bell on Thursday, February 17, alongside CTO Dr. Mark McCord and members of both, Cepton Technologies and Growth Capital […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics

Psychedelic drugs are on cusp of entering mainstream treatment for mental illness Cybin, Chopra Foundation to collaborate on efforts aimed to support education, awareness about psychedelic therapy mental health research Cybin “one of the only companies that may truly address the needs of patients and providers,” says Dr. Deepak Chopra A significant increase in research […]

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company […]

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Keeping a Close Eye on the Evolving Geopolitical Situation, and its Impact on Risk-Taking

The price of gold has increased by 6.5% to reach an 18-month high of $1,973.96 Palladium has also increased by 5.1% in value for the third consecutive month Gold is proving to be the main safe-haven asset with the growing tensions StraightUp acknowledges a change in shareholders’ willingness to take more risks but looks to […]

Friendable Inc. (FDBL) Creates “Anti-Label” Movement with Fan Pass Live Artist Platform and Newly Acquired Artist Republik

Fan Pass Live was released by Friendable in July 2020, and Artist Republik’s acquisition was completed in January 2022 Friendable is positioned to leverage two markets – music streaming and music distribution services, capitalizing on technological advancements and the shift to digital platforms The global music streaming market was valued at $24.4 billion in 2020 […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention

May 15, 2026

Most people are aware that cardiovascular disease (“CVD”) is the leading cause of death in the United States; what they might not know is that an estimated 80% of those cases are considered preventable through earlier detection and proactive management of key risk factors. This highlights the urgent need for more effective tools that can […]

Rotate your device 90° to view site.